Lee, Jenny H.
Shklovskaya, Elena
Lim, Su Yin
Carlino, Matteo S.
Menzies, Alexander M.
Stewart, Ashleigh
Pedersen, Bernadette
Irvine, Malama
Alavi, Sara
Yang, Jean Y. H. http://orcid.org/0000-0002-5271-2603
Strbenac, Dario
Saw, Robyn P. M. http://orcid.org/0000-0002-3354-806X
Thompson, John F. http://orcid.org/0000-0002-2816-2496
Wilmott, James S. http://orcid.org/0000-0002-6750-5244
Scolyer, Richard A.
Long, Georgina V.
Kefford, Richard F.
Rizos, Helen http://orcid.org/0000-0002-2094-9198
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1130423, APP1099963)
Article History
Received: 4 July 2019
Accepted: 26 March 2020
First Online: 20 April 2020
Competing interests
: J.H.L. has received honoraria from AstraZeneca and travel support from BMS. G.L. receives consultant service fees from Amgen, BMS, Array, Pierre Fabre, Novartis, MSD, and Roche. A.M.M. is on the advisory board of BMS, Merck (MSD), Novartis, Roche, and Pierre Fabre. R.F.K. has been on advisory boards for Roche, Amgen, BMS, MSD, Novartis and TEVA and has received honoraria from MSD, BMS and Novartis. M.C. is an advisory board member for MSD, BMS, Novartis and Amgen. The remaining authors declare no competing interests.